{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:23:24Z","timestamp":1787664204192,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ae0121009"],"award-info":[{"award-number":["JP25ae0121009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Efficient and stable production of recombinant monoclonal antibodies requires sufficient expression of light (LC) and heavy (HC) chains within host cells. Conventional bicistronic systems such as internal ribosome entry site (IRES)- or 2\u00a0A peptide\u2013based vectors often suffer from imbalanced translation efficiencies or the presence of residual peptide tags that can compromise antibody quality. We developed a novel bicistronic expression platform, designated the cassette exon\u2013associated (CAE) system, which exploits alternative splicing derived from the HEG1 gene to generate two mRNA isoforms from a single promoter. The CAE cassette contains synthetic splice donor and acceptor sequences that enable expression of LC and HC without additional peptide sequences. The optimized construct, pCAE3.31, driven by various promoters\u2014including chicken \u03b2-actin, cytomegalovirus, and human elongation factor-1\u03b1\u2014efficiently expressed functional antibodies in multiple mammalian cell lines. Compared with IRES-based systems, the CAE vector achieved an 8-fold higher antibody yield. Fab fragments were also produced using the CAE system. The CAE system represents a compact and versatile bicistronic expression strategy that ensures expression of LC and HC, avoids extraneous peptide fusion, and is compatible with major mammalian promoters. This platform facilitates efficient production of recombinant antibodies and Fab fragments, supporting screening and potential therapeutic applications.<\/jats:p>","DOI":"10.1038\/s41598-026-57819-1","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:15:32Z","timestamp":1781180132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel bicistronic vector inducing balanced alternative splicing for antibody production"],"prefix":"10.1038","volume":"16","author":[{"given":"Shoutaro","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"57819_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/abt\/tbac021","volume":"5","author":"X Lyu","year":"2022","unstructured":"Lyu, X. et al. The global landscape of approved antibody therapies. Antib. Ther. 5, 233\u2013257. https:\/\/doi.org\/10.1093\/abt\/tbac021 (2022).","journal-title":"Antib. Ther."},{"key":"57819_CR2","doi-asserted-by":"publisher","unstructured":"Li, F., Vijayasankaran, N., Shen, A. Y., Kiss, R. & Amanullah, A. Cell culture processes for monoclonal antibody production. mAbs 2, 466\u2013479, (2010). https:\/\/doi.org\/10.4161\/mabs.2.5.12720","DOI":"10.4161\/mabs.2.5.12720"},{"key":"57819_CR3","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1093\/nar\/27.19.3792","volume":"27","author":"P Kreiss","year":"1999","unstructured":"Kreiss, P. et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 27, 3792\u20133798. https:\/\/doi.org\/10.1093\/nar\/27.19.3792 (1999).","journal-title":"Nucleic Acids Res."},{"key":"57819_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/bp049780w","volume":"21","author":"S Schlatter","year":"2005","unstructured":"Schlatter, S. et al. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol. Prog. 21, 122\u2013133. https:\/\/doi.org\/10.1021\/bp049780w (2005).","journal-title":"Biotechnol. Prog"},{"key":"57819_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/334320a0","volume":"334","author":"J Pelletier","year":"1988","unstructured":"Pelletier, J. & Sonenberg, N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320\u2013325. https:\/\/doi.org\/10.1038\/334320a0 (1988).","journal-title":"Nature"},{"key":"57819_CR6","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/JVI.62.8.2636-2643.1988","volume":"62","author":"SK Jang","year":"1988","unstructured":"Jang, S. K. et al. A segment of the 5\u2032 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636\u20132643. https:\/\/doi.org\/10.1128\/JVI.62.8.2636-2643.1988 (1988).","journal-title":"J. Virol."},{"key":"57819_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/pharmaceutics11110580","volume":"11","author":"AA Shaimardanova","year":"2019","unstructured":"Shaimardanova, A. A. et al. Production and application of multicistronic constructs for various human disease therapies. Pharmaceutics 11, 580. https:\/\/doi.org\/10.3390\/pharmaceutics11110580 (2019).","journal-title":"Pharmaceutics"},{"key":"57819_CR8","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.3390\/ijms22105193","volume":"22","author":"GGH van den Akker","year":"2021","unstructured":"van den Akker, G. G. H. et al. Current practice in bicistronic IRES reporter use: a systematic review. Int. J. Mol. Sci. 22, 5193. https:\/\/doi.org\/10.3390\/ijms22105193 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"57819_CR9","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3390\/biomedicines10081865","volume":"10","author":"R Marques","year":"2022","unstructured":"Marques, R., Lacerda, R. & Rom\u00e3o, L. Internal ribosome entry site (IRES)-mediated translation and its potential for novel mRNA-based therapy development. Biomedicines 10, 1865. https:\/\/doi.org\/10.3390\/biomedicines10081865 (2022).","journal-title":"Biomedicines"},{"key":"57819_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E. & Hayakawa, T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 1, 376\u2013382. https:\/\/doi.org\/10.1006\/mthe.2000.0050 (2000).","journal-title":"Mol. Ther."},{"key":"57819_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jbiotec.2011.09.023","volume":"157","author":"SC Ho","year":"2012","unstructured":"Ho, S. C. et al. IRES-mediated tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. J. Biotechnol. 157, 130\u2013139. https:\/\/doi.org\/10.1016\/j.jbiotec.2011.09.023 (2012).","journal-title":"J. Biotechnol."},{"key":"57819_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1099\/0022-1317-82-5-1013","volume":"82","author":"MLL Donnelly","year":"2001","unstructured":"Donnelly, M. L. L. et al. Analysis of the aphthovirus 2A\/2B polyprotein cleavage mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal skip. J. Gen. Virol. 82, 1013\u20131025. https:\/\/doi.org\/10.1099\/0022-1317-82-5-1013 (2001).","journal-title":"J. Gen. Virol."},{"key":"57819_CR13","doi-asserted-by":"publisher","first-page":"e63247","DOI":"10.1371\/journal.pone.0063247","volume":"8","author":"SC Ho","year":"2013","unstructured":"Ho, S. C. et al. Comparison of internal ribosome entry site (IRES) and furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells. PLoS ONE. 8, e63247. https:\/\/doi.org\/10.1371\/journal.pone.0063247 (2013).","journal-title":"PLoS ONE"},{"key":"57819_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","volume":"7","author":"J Chng","year":"2015","unstructured":"Chng, J. et al. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells. mAbs 7, 403\u2013412. https:\/\/doi.org\/10.1080\/19420862.2015.1008351 (2015).","journal-title":"mAbs"},{"key":"57819_CR15","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1093\/nar\/gkp716","volume":"37","author":"S Fallot","year":"2009","unstructured":"Fallot, S. et al. Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production. Nucleic Acids Res. 37, e134. https:\/\/doi.org\/10.1093\/nar\/gkp716 (2009).","journal-title":"Nucleic Acids Res."},{"key":"57819_CR16","doi-asserted-by":"publisher","first-page":"45768","DOI":"10.1038\/srep45768","volume":"7","author":"S Tsuji","year":"2017","unstructured":"Tsuji, S. et al. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci. Rep. 7, 45768. https:\/\/doi.org\/10.1038\/srep45768 (2017).","journal-title":"Sci. Rep."},{"key":"57819_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrg.2016.46","volume":"17","author":"CR Sibley","year":"2016","unstructured":"Sibley, C. R., Blazquez, L. & Ule, J. Lessons from non-canonical splicing. Nat. Rev. Genet. 17, 407\u2013421. https:\/\/doi.org\/10.1038\/nrg.2016.46 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"57819_CR18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1073\/pnas.1616408114","volume":"114","author":"T Jain","year":"2017","unstructured":"Jain, T. et al. Biophysical properties of the clinical-stage antibody landscape. Proc. Natl. Acad. Sci. USA. 114, 944\u2013949. https:\/\/doi.org\/10.1073\/pnas.1616408114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57819_CR19","doi-asserted-by":"publisher","first-page":"e10611","DOI":"10.1371\/journal.pone.0010611","volume":"5","author":"JY Qin","year":"2010","unstructured":"Qin, J. Y. et al. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS ONE. 5, e10611. https:\/\/doi.org\/10.1371\/journal.pone.0010611 (2010).","journal-title":"PLoS ONE"},{"key":"57819_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0168-1656(01)00388-1","volume":"93","author":"SY Kim","year":"2002","unstructured":"Kim, S. Y., Lee, J. H., Shin, H. S., Kang, H. J. & Kim, Y. S. The human elongation factor 1 alpha (EF-1\u03b1) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter. J. Biotechnol. 93, 183\u2013187. https:\/\/doi.org\/10.1016\/S0168-1656(01)00388-1 (2002).","journal-title":"J. Biotechnol."},{"key":"57819_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/protein\/gzm038","volume":"20","author":"J Li","year":"2007","unstructured":"Li, J., Zhang, C., Jostock, T. & D\u00fcbel, S. Analysis of IgG heavy chain to light chain ratio with mutant encephalomyocarditis virus internal ribosome entry site. Protein Eng. Des. Sel. 20, 491\u2013496. https:\/\/doi.org\/10.1093\/protein\/gzm038 (2007).","journal-title":"Protein Eng. Des. Sel."},{"key":"57819_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1389-1723(04)00285-3","volume":"98","author":"A Hotta","year":"2004","unstructured":"Hotta, A. et al. Production of anti-CD2 chimeric antibody by recombinant animal cells. J. Biosci. Bioeng. 98, 298\u2013303. https:\/\/doi.org\/10.1016\/S1389-1723(04)00285-3 (2004).","journal-title":"J. Biosci. Bioeng."},{"key":"57819_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jbiotec.2013.03.019","volume":"165","author":"SC Ho","year":"2013","unstructured":"Ho, S. C. et al. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. J. Biotechnol. 165, 157\u2013166. https:\/\/doi.org\/10.1016\/j.jbiotec.2013.03.019 (2013).","journal-title":"J. Biotechnol."},{"key":"57819_CR24","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/bit.22158","volume":"102","author":"J Chusainow","year":"2009","unstructured":"Chusainow, J. et al. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? Biotechnol. Bioeng. 102, 1182\u20131196. https:\/\/doi.org\/10.1002\/bit.22158 (2009).","journal-title":"Biotechnol. Bioeng."},{"key":"57819_CR25","doi-asserted-by":"publisher","first-page":"14251","DOI":"10.1038\/s41598-018-32534-8","volume":"8","author":"R Matsuura","year":"2018","unstructured":"Matsuura, R. et al. Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1. Sci. Rep. 8, 14251. https:\/\/doi.org\/10.1038\/s41598-018-32534-8 (2018).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57819-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:02:44Z","timestamp":1787662964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57819-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.T. is listed as an inventor on a patent application covering this study. Patent application number is JP2026-012146.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26632"}}